home / stock / mdwd / mdwd news


MDWD News and Press, MediWound Ltd. From 05/14/19

Stock Information

Company Name: MediWound Ltd.
Stock Symbol: MDWD
Market: NASDAQ
Website: mediwound.com

Menu

MDWD MDWD Quote MDWD Short MDWD News MDWD Articles MDWD Message Board
Get MDWD Alerts

News, Short Squeeze, Breakout and More Instantly...

MDWD - MediWound to Host First Quarter Financial Results Conference Call on May 21at 8:30 a.m. Eastern Time

YAVNE, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the f...

MDWD - Vericel nabs North American rights to MediWound's NexoBrid

MediWound (NASDAQ: MDWD ) has out-licensed exclusive rights to debridement agent NexoBrid to Vericel (NASDAQ: VCEL ) in North America. More news on: MediWound Ltd., Vericel Corporation, Healthcare stocks news, Stocks on the move, Read more ...

MDWD - MediWound Enters into Exclusive License Agreement with Vericel for Commercial Rights to NexoBrid® in North America

$17.5 million upfront, sales royalties and up to $132.5 million in potential milestones Leverages Vericel’s Commercial Capabilities and Presence in U.S. Burn Care Market Biologics License Application (BLA) Filing Planned for Fourth Quarter of 2019 Company to Host a Conference ...

MDWD - MediWound Files Annual Report on Form 20-F for the Year Ended December 31, 2018

YAVNE, Israel, March 26, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that it has filed its annual report on Form 20-F for the ...

MDWD - MediWound (MDWD) CEO, Gal Cohen on Q4 2018 Results - Earnings Call Transcript

MediWound Ltd. (MDWD) Q4 2018 Earnings Conference Call March 25, 2019 9:00 am ET Company Participants Steve Wills - Active Chairman of the Board Gal Cohen - President, Chief Executive Officer Sharon Malka - Chief Financial Officer Jeremy Feffer - Investor Relations Conferen...

MDWD - MediWound EPS of $0.22

MediWound (NASDAQ: MDWD ): Q4 EPS of $0.22 may not be comparable to consensus of -$0.15. More news on: MediWound Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

MDWD - MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Met Primary and All Secondary Endpoints in its Pivotal Phase 3 Study (DETECT) in NexoBrid ® for Eschar Removal of Severe Thermal Burns Awarded Additional BARDA Contract Valued up to $43 Million for the Development of NexoBrid for Sulfur Mustard Injuries Conference call begin...

MDWD - Apple Makes Its Video-Streaming Move (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

MDWD - Stocks To Watch: Apple Makes Its Video-Streaming Move

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The increasingly hot market for online video delivery is set to take another sharp ...

MDWD - MediWound to Host Fourth Quarter & Fiscal 2018 Financial Results Conference Call on March 25 at 8:30 a.m. Eastern Time

YAVNE, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the...

Previous 10 Next 10